marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
.
recommended:
.media won�t investigate medically-caused death numbers
.
.
.